Skip to main content

News and Announcements

Read the latest news from Northwestern University Feinberg School of Medicine’s Mesulam Center for Cognitive Neurology and Alzheimer's Disease. The links below take you to articles where you can learn more about our members' latest achievements, awards and honors.

  • 06.10.2024 Yahoo Canada

    Joshua Cahan, MD, highlighted safety concerns with new anti-amyloid monoclonal antibodies, as FDA advisers meet to assess Eli Lilly's Alzheimer's drug, donanemab. This decision could shape future therapies for Alzheimer's patients.

  • 06.05.2024 Buzzfeed

    Experts, including the Mesulam Center's Tamar Gefen, PhD, highlight the unique qualities of "SuperAgers". While no specific trick ensures becoming a SuperAger, engaging in regular physical activity, maintaining social connections, and reducing stress are key practices observed among them.

  • 06.04.2024

    The Mesulam Center for Cognitive Neurology and Alzheimer’s Disease celebrated its 30th Annual Alzheimer’s Day on May 3, 2024, where researchers and community members came together to learn about recent accomplishments in the field, early-onset Alzheimer’s and community efforts raising awareness for those experiencing cognitive decline.

    The post Mesulam Center Celebrates 30th Annual Alzheimer Day appeared first on News Center.

  • 06.04.2024 Better Edge Podcast
    Borna Bonakdarpour, MD sat down with Northwestern Medicine's Better Edge podcast to discuss the highlights from the 2024 American Academy of Neurology (AAN) Annual Meeting. Dr. Bonakdarpour discusses leveraging the learnings from the meeting by incorporating the latest research and treatment approaches into patient care.
  • 06.03.2024

    The Mesulam Center for Cognitive Neurology and Alzheimer’s Disease celebrated its 30th Annual Alzheimer Day on May 3, 2024, where researchers and community members came together to learn about recent accomplishments in the field, early-onset Alzheimer’s and community efforts raising awareness for those experiencing cognitive decline. 

  • 05.18.2024

    For decades, Marcus Peter, PhD, has drilled into an area of research focused on cell death and the roles of toxic and protective short RNAs, with the goal of developing a novel form of cancer treatment. Now, this same line of research has led Peter’s team to uncover new insights into the cause of Alzheimer’s disease. In this episode, Peter explains his pioneering work in investigating RNA interference in diseases and explains how his lab’s latest novel discovery may have relevance to an array of neurodegenerative diseases beyond Alzheimer’s.

  • 05.15.2024 Research Renaissance
    Elena Barbieri recently sat down with the Research Renaissance podcast to discuss primary progressive aphasia (PPA), a rare neurological disorder progressively impairs the ability to speak and understand language while other cognitive functions remain relatively intact.
  • 05.10.2024

    A unique genetic variation in the MAPT gene was associated with increased risk of Pick’s disease, a rare form of frontotemporal dementia, according to a recent study published in The Lancet Neurology.

    The post Genetic Variation Linked to Increased Risk of Pick’s Disease appeared first on News Center.

  • 05.06.2024 WBEZ Chicago
    Families are often the first line of defense in the fight against degenerative brain diseases, and experts say early intervention is key. The Mesulam Center's Molly Mather, PhD and Lauren Dowden, MSW, LCSW discuss the family's role in diagnosis and treatment. 
  • 04.11.2024

    Recent studies from Feinberg scientists have uncovered new insights into these disorders, elucidating the mechanisms behind Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis, or ALS.

  • 04.10.2024 Buffalo News
    The West Falls Musical Memories Cafe provides a space for joy and connections amidst the challenges of Alzheimer's and dementia. Experts, including Borna Bonakdarpour spoke about the therapeutic potential of music and community, illuminating the path to emotional well-being for those affected.
  • 04.10.2024 Everyday Health
    Discover how the brain evolves with age, navigating between normal aging and cognitive concerns, as explained by experts like Molly Mather. Unveil insights into the fascinating world of 'SuperAgers,' individuals over 80 with memory abilities akin to those decades younger, shedding light on potential keys to maintaining brain health.
  • 04.05.2024

    Northwestern Medicine investigators have developed a method to measure protein expression in an individual neuron type, according to a study published in Molecular Psychiatry.

  • 04.03.2024
    We recently talked to Mesulam Center researchers, those of whom are involved in primary progressive aphasia (PPA) research, about a unique gift many of our research participants have left behind at the Center — their artwork. Discover how art becomes a profound means of communication and expression amidst language loss, leaving a lasting legacy at the Mesulam Center and beyond.
  • 04.03.2024

    The Mesulam Center for Cognitive Neurology and Alzheimer's Disease initiated the Northwestern University SuperAging Program (NUSAP) 25 years ago to show that the preservation of memory into the 80’s and beyond does happen and that a long life does not necessarily lead to Alzheimer’s disease. We are immensely grateful to all of our participants for generously donating their time and wisdom year after year and look forward to continue working together for many years to come. Read our full statement.

  • 03.11.2024

    A mutated protein expressed in lysosomes may contribute to Parkinson’s disease, according to a new Northwestern Medicine study published in the Journal of Cell Biology.

  • 02.26.2024 CBS News
    The news of Wendy Williams' dementia-linked diagnoses is an important reminder that the conditions are often missed initially by medical providers, according to Dr. Sandra Weintraub, a clinician and neuropsychologist at Northwestern University, who joined CBS News with a look at the medical effects.
  • 02.23.2024 NBC 5 Chicago
    Former talk show host Wendy Williams announced on February 22 that she has been diagnosedn frontotemporal dementia (FTD) and primary progressive aphasia (PPA), a progressive disorder that makes it difficult for a person to understand and express language. Sandra Weintraub, PhD discusses common sympotoms of FTD and PPA.
  • 02.23.2024 Northwestern Medicine Magazine
    Robert Vassar, PhD, director of the Mesulam Center, shares his journey from groundbreaking discoveries in molecular genetics to leading the charge against Alzheimer's. With FDA-approved treatments and cutting-edge research, his goal is simple — to make dementia just a memory.
  • 02.14.2024

    A new study has found the immune system in the blood of Alzheimer’s patients is epigenetically altered, and many of these altered genes are the same ones that increase an individual’s risk for Alzheimer’s.

  • 02.14.2024 WTTW
    As questions about age and cognitive function have once again surfaced in the presidential race, Molly Mather, PhD discusses what you should know about brain health.
  • 02.12.2024 CNN

    Concerns about age and mental fitness have been a recurring theme through the past two presidencies and are set to only mount in 2024 with two frontrunner candidates nearing or exceeding the age of 80. Experts, including Molly Mather, PhD discuss typical signs of aging.

  • 02.05.2024 Alz Forum
    Clinicians, led by Gil Rabinovici at UCSF, found that a rare type of early-onset dementia called posterior cortical atrophy (PCA) is usually linked to Alzheimer's disease. This form of dementia affects how people see and process things and often starts around age 60, particularly in women, with challenges in getting a correct diagnosis, emphasizing the importance of raising awareness among eye-care specialists and neurologists. Marsel Mesulam spoke on the significance of this paper and their findings. 
  • 02.02.2024 OHBM Neurosalience Podcas

    Marsel Mesulam, MD recently joined the Organization of Human Brain Mapping (OHBM) Neurosalience Podcast to discuss his influential career and current research focuses.

  • 02.01.2024 WGN

    On January 31, 2024, Biogen announced that they will be discontinuing production of their controversial Alzheimer's drug Aduhelm, less than 3 years after receiving FDA approval. Ian Grant, MD spoke to WGN about the discontinuation of the drug and alternative medication options, such as Lecanemab, which has shown a 27-28% slowing of cognitive decline in studies.

  • 01.23.2024

    Sandra Weintraub, PhD and a group of researchers from around the country have spent the past few years developing the Dementia Nomenclature Initiative (DeNomI), a nationwide plan to address limitations in communicating dementia diagnoses and increase the general public’s understanding of related diseases. This first-of-its-kind framework aims to tackle stigma, naming inconsistencies, and a lack of education surrounding cognitive diseases. DeNomI separates clinical symptoms from biological changes, paving the way for improved research, therapy development, and enhanced healthcare communication.

  • 01.19.2024

    A new Northwestern Medicine study has identified short strands of toxic RNAs that contribute to brain cell death and DNA damage in Alzheimer’s and aged brains.

    The post New Cause of Neuron Death in Alzheimer’s Discovered appeared first on News Center.

  • 01.19.2024 NeurologyToday

    Patients planning to receive anti-amyloid treatments such as lecanemab first must enroll in a registry to help clinicians draw conclusions on the drugs' safety and efficacy. But multiple registries have been established and are now asking for different data and using varied scales, raising questions about the integrity of the data collected and how it could be shared among the registries.

  • 01.16.2024 HuffPost

    Remaining healthy and sharp are goals for most people as they age. But one group of people — known as “SuperAgers” — is said to have this all down as they go through life, even into their later years. Tamar Gefen, PhD shares some key behaviors that can improve your life expectancy.

Follow Mesulam Center on Facebook